Pathway-based signature analysis of RNA-seq data to reveal new targetable avenues for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Adrian Bivol, Robert Baertsch, Artem Sokolov, Evan Paull, Yulia Newton, Theodore C. Goldstein, Adam Foye, Nader Pourmand, Jack Youngren, Rahul Parulkar, Asis Lopez, Ralph de Vere White, Joshi J. Alumkal, Alexandria Toschi, Tomasz M. Beer, Christopher P. Evans, Martin Edwin Gleave, Owen Witte, Eric Jay Small, Joshua M. Stuart
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2906795442
